FOXO3 and cardiac hypertrophy: Suppression of cardiac hypertrophy via inhibition of calcineurin-NFAT pathway by polyubiquitination and degradation of the calcineurin A together with SCF complex and through K63-linked polyubiquitination of Foxo1 and Foxo3a